CuraScientific Corp.
CSTF
$0.00
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 230.30K | 441.40K | -- | 0.00 | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 230.30K | 441.40K | -- | 0.00 | -- |
| Cost of Revenue | 795.80K | 494.70K | 150.00K | 600.00K | 150.00K |
| Gross Profit | -565.50K | -53.30K | -150.00K | -600.00K | -150.00K |
| SG&A Expenses | 315.10K | 1.01M | 146.80K | 494.60K | 460.70K |
| Depreciation & Amortization | 4.90K | 4.70K | 3.80K | 4.30K | 4.30K |
| Other Operating Expenses | -- | -- | -- | -450.00K | -- |
| Total Operating Expenses | 1.12M | 1.51M | 300.50K | 648.90K | 614.90K |
| Operating Income | -885.50K | -1.07M | -300.50K | -648.90K | -614.90K |
| Income Before Tax | -5.72M | 41.27M | -216.30K | -1.66M | 194.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.72M | 41.27M | -216.30K | -1.66M | 194.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.72M | 41.27M | -216.30K | -1.66M | 194.10K |
| EBIT | -885.50K | -1.07M | -300.50K | -648.90K | -614.90K |
| EBITDA | -205.40K | -792.20K | -146.80K | -494.60K | -460.70K |
| EPS Basic | -0.01 | 0.39 | -0.03 | -0.25 | 0.03 |
| Normalized Basic EPS | 0.00 | 0.26 | 0.05 | -0.12 | -0.19 |
| EPS Diluted | -0.01 | 0.29 | -0.03 | -0.25 | 0.03 |
| Normalized Diluted EPS | 0.00 | 0.19 | 0.05 | -0.12 | -0.19 |
| Average Basic Shares Outstanding | 756.68M | 105.97M | 6.82M | 6.68M | 6.39M |
| Average Diluted Shares Outstanding | 756.68M | 142.44M | 6.82M | 6.68M | 6.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
